location:Home >News > Biological News

Biological News

Progress in drug treatment of refractory prolactinoma

Prolactinoma is the most common functional pituitary adenoma, accounting for 47%-66% of functional pituitary adenomas. It often causes amenorrhea, lactation, decreased libido and sexual dysfunction due to excessive secretion of prolactin (PRL).


Research leads to better understanding of the immune system in kidney cancer

In the last two decades, immunotherapy has emerged as a leading treatment for advanced renal carcinoma cancer (more commonly known as kidney cancer).


´Friendly′ bacteria may impact COVID severity

The U.S. Centers for Disease Control and Prevention (CDC) has awarded Vanderbilt University Medical Center a two-year, $3.7-million contract to determine genetic and bacterial factors that may increase the risk for severe illness and death from COVID-19.


Evaluation of serum ATX and LPA as potential diagnostic biomarkers in patients with pancreatic cancer

Pancreatic cancer (PC) is a devastating disease that has a poor prognosis and a total 5-year survival rate of around 5%.


A role of PIEZO1 in iron metabolism in mice and humans

Iron is essential for cellular processes such as hemoglobin biosynthesis for oxygen transport. However, too much iron is toxic to organs ,thus, iron levels are tightly controlled by homeostatic processes.


HbA1c is closely related to the risk of cardiovascular events

A retrospective analysis of more than 29000 U.S. patients found that patients with type 2 diabetes mellitus (T2DM) with similar overall levels of glycosylated hemoglobin (HbA1c) had significantly higher risk of cardiovascular disease (CVD) events than patients with type 2 diabetes mellitus (T2DM).


[<] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [>] - [>>] ...[40]
235 records page 6 / 40
Abebio News
Biological News
 Wuhan Abebio Science Co.,Ltd
 Room 002,15F-D2,3rd Phase of Software New Park, No.8 Huacheng Avenue, East Lake New-tech Development Zone,Wuhan,China
Email: abebio@abebio.com